Zhang, Y., Black, K. E., Phung, T.-K. N., Thundivalappil, S. R., Lin, T., Wang, W., Xu, J., Zhang, C., Hariri, L. P., Lapey, A., Li, H., Lerou, P. H., Ai, X., Que, J., Park, J.-A., Hurley, B. P., & Mou, H. (2023). Human Airway Basal Cells Undergo Reversible Squamous Differentiation and Reshape Innate Immunity. American Journal of Respiratory Cell and Molecular Biology, 68(6), 664–678. https://doi.org/10.1165/rcmb.2022-0299oc

Okolo, O., Yu, V., Flashner, S., Martin, C., Nakagawa, H., Lin, D. T., Puram, S. V., & Parikh, A. S. (2023). Protocol for tumor dissociation and fluorescence-activated cell sorting of human head and neck cancers. STAR Protocols, 4(2), 102294. https://doi.org/10.1016/j.xpro.2023.102294

Lee, A. J., Goodman, S., Corradini, B., Cohn, S., Chatterji, M., & Landau, R. (2023). A serious video game—EmergenCSim™—for novice anesthesia trainees to learn how to perform general anesthesia for emergency cesarean delivery: a randomized controlled trial. Anesthesiology and Perioperative Science, 1(2). https://doi.org/10.1007/s44254-023-00016-4

Chakraborty, R., Yi, J., Rybicki, L., Preussler, J., Deol, A., Loren, A., Savani, B., Jim, H. S. L., Cerny, J., Reynolds, J., Whitten, J., Wingard, J. R., McGuirk, J. P., Uberti, J., Khera, N., Stiff, P., Jaglowski, S. M., Hashmi, S., Holtan, S. G., … Majhail, N. S. (2023). Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Transplantation and Cellular Therapy, 29(6), 388.e1-388.e6. https://doi.org/10.1016/j.jtct.2023.02.011

Mair, M. J., Bartsch, R., Le Rhun, E., Berghoff, A. S., Brastianos, P. K., Cortes, J., Gan, H. K., Lin, N. U., Lassman, A. B., Wen, P. Y., Weller, M., van den Bent, M., & Preusser, M. (2023). Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours. Nature Reviews Clinical Oncology, 20(6), 372–389. https://doi.org/10.1038/s41571-023-00756-z

Thomas, A. S., Gleit, Z., Younan, S., Genkinger, J., & Kluger, M. D. (2023). High rate of stone-related complications after stapling the cystic duct during laparoscopic cholecystectomy—an underrecognized risk. Surgical Endoscopy, 37(6), 4707–4718. https://doi.org/10.1007/s00464-023-09947-2

Chen, Q., Weng, K., Lin, M., Jiang, M., Fang, Y., Chung, S. S. W., Huang, X., Zhong, Q., Liu, Z., Huang, Z., Lin, J., Li, P., El-Rifai, W., Zaika, A., Li, H., Rustgi, A. K., Nakagawa, H., Abrams, J. A., Wang, T. C., … Que, J. (2023). SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division. Gastroenterology, 164(7), 1119-1136.e12. https://doi.org/10.1053/j.gastro.2023.01.037

Quante, M., Wang, T. C., & Bass, A. J. (2022). Adenocarcinoma of the oesophagus: is it gastric cancer? Gut, 72(6), 1027–1029. https://doi.org/10.1136/gutjnl-2022-327096

Liang, D., Feng, Y., Zandkarimi, F., Wang, H., Zhang, Z., Kim, J., Cai, Y., Gu, W., Stockwell, B. R., & Jiang, X. (2023). Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell, 186(13), 2748-2764.e22. https://doi.org/10.1016/j.cell.2023.05.003

Liu, Y., Liu, Y., Ye, S., Feng, H., & Ma, L. (2023). A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients. Journal of Translational Internal Medicine, 11(2), 145–155. https://doi.org/10.2478/jtim-2023-0089

Jurczak, W., Lamanna, N., Tam, C. S., Kontos, A., Konig, H., Ruppert, A. S., & Tsai, D. E. (2023). COMPARISON OF BLEEDING‐RELATED EVENTS IN PATIENTS WHO RECEIVED PIRTOBRUTINIB WITH AND WITHOUT ANTITHROMBOTIC AGENTS. Hematological Oncology, 41(S2), 758–759. Portico. https://doi.org/10.1002/hon.3165_605

Mehta‐Shah, N., Jacobsen, E. D., Zinzani, P. L., Zain, J., Mead, M., Casulo, C., Gritti, G., Pinter‐Brown, L., Izutsu, K., Waters, S., Brammer, J. E., Pro, B., & Horwitz, S. M. (2023). Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: outcomes by baseline histology. Hematological Oncology, 41(S2), 499–500. Portico. https://doi.org/10.1002/hon.3164_367

Eichhorst, B., Lamanna, N., O’Brien, S. M., Tam, C. S., Qiu, L., Yang, K., Wu, K., Salmi, T., Barnes, G., & Brown, J. R. (2023). Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma (R/R CLL/SLL): Impact on health‐related quality of life. Hematological Oncology, 41(S2), 463–464. Portico. https://doi.org/10.1002/hon.3164_341

Michel, A., Lee, R. T., Salehi, E., & Accordino, M. K. (2023). Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book, 43. https://doi.org/10.1200/edbk_390428

Botta, S., de Prisco, N., Chemiakine, A., Brandt, V., Cabaj, M., Patel, P., Doron‐Mandel, E., Treadway, C. J., Jovanovic, M., Brown, N. G., Soni, R. K., & Gennarino, V. A. (2023). Dosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms. The EMBO Journal, 42(11). Portico. https://doi.org/10.15252/embj.2022112721

Beauchemin, M. P., Roth, M. E., & Parsons, S. K. (2023). Reducing Adolescent and Young Adult Cancer Outcome Disparities Through Optimized Care Delivery: A Blueprint from the Children’s Oncology Group. Journal of Adolescent and Young Adult Oncology. https://doi.org/10.1089/jayao.2022.0136

Vize, C. J., Kim, S. K., Matthews, T., Macsai, M., Merrell, R., Hsu, S., Kundu, M. G., Yoon, J., Kennedy, E., Pai, M., Bain, E., Lassman, A. B., & Moazami, G. (2023). A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin. Ophthalmic Research, 1030–1043. Portico. https://doi.org/10.1159/000531142

Wu, J. Y., Yeager, K., Tavakol, D. N., Morsink, M., Wang, B., Soni, R. K., Hung, C. T., & Vunjak-Novakovic, G. (2023). Directed differentiation of human iPSCs into mesenchymal lineages by optogenetic control of TGF-β signaling. Cell Reports, 42(5), 112509. https://doi.org/10.1016/j.celrep.2023.112509

Bagde, H., & Manjrekar, K. B. (2023). Oral and System Health: Real Collaboration for Innovations in Healthcare and Policy. Bangladesh Journal of Medical Science, 1–3. https://doi.org/10.3329/bjms.v22i20.66299

Baker, S. D., Bates, S. E., Brooks, G. A., Dahut, W. L., Diasio, R. B., El-Deiry, W. S., Evans, W. E., Figg, W. D., Hertz, D. L., Hicks, J. K., Kamath, S., Kasi, P. M., Knepper, T. C., McLeod, H. L., O’Donnell, P. H., Relling, M. V., Rudek, M. A., Sissung, T. M., Smith, D. M., … Walko, C. M. (2023). DPYD Testing: Time to Put Patient Safety First. Journal of Clinical Oncology, 41(15), 2701–2705. https://doi.org/10.1200/jco.22.02364

Fong, A. J., Llanos, A. A. M., Ashrafi, A., Zeinomar, N., Chokshi, S., Bandera, E. V., Devine, K. A., Hudson, S. V., Qin, B., O’Malley, D., Paddock, L. E., Stroup, A. M., Evens, A. M., & Manne, S. L. (2023). Sociodemographic and Health Correlates of Multiple Health Behavior Adherence among Cancer Survivors: A Latent Class Analysis. Nutrients, 15(10), 2354. https://doi.org/10.3390/nu15102354

Wang, M. L., Jurczak, W., Zinzani, P. L., Eyre, T. A., Cheah, C. Y., Ujjani, C. S., Koh, Y., Izutsu, K., Gerson, J. N., Flinn, I., Tessoulin, B., Alencar, A. J., Ma, S., Lewis, D., Lech-Maranda, E., Rhodes, J., Patel, K., Maddocks, K., Lamanna, N., … Shah, N. N. (2023). Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma. Journal of Clinical Oncology, 41(24), 3988–3997. https://doi.org/10.1200/jco.23.00562

Bernstein, E., Lev-Ari, S., Shapira, S., Leshno, A., Sommer, U., Al-Shamsi, H., Shaked, M., Segal, O., Galazan, L., Hay-Levy, M., Sror, M., Harlap-Gat, A., Peer, M., Moshkowitz, M., Wolf, I., Liberman, E., Shenberg, G., Gur, E., Elran, H., … Arber, N. (2023). Data From a One-Stop-Shop Comprehensive Cancer Screening Center. Journal of Clinical Oncology, 41(14), 2503–2510. https://doi.org/10.1200/jco.22.00938

Perez, K., Chiarella, A. M., Cleary, J. M., Horick, N., Weekes, C., Abrams, T., Blaszkowsky, L., Enzinger, P., Giannakis, M., Goyal, L., Meyerhardt, J. A., Rubinson, D., Yurgelun, M. B., Goessling, W., Giantonio, B. J., Brais, L., Germon, V., Stonely, D., Raghavan, S., … Wolpin, B. M. (2023). Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer. The Oncologist, 28(5), 425–432. https://doi.org/10.1093/oncolo/oyad002

Obradovic, A., Ager, C., Turunen, M., Nirschl, T., Khosravi-Maharlooei, M., Iuga, A., Jackson, C. M., Yegnasubramanian, S., Tomassoni, L., Fernandez, E. C., McCann, P., Rogava, M., DeMarzo, A. M., Kochel, C. M., Allaf, M., Bivalacqua, T., Lim, M., Realubit, R., Karan, C., … Califano, A. (2023). Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators. Cancer Cell, 41(5), 933-949.e11. https://doi.org/10.1016/j.ccell.2023.04.003

Cannioto, R. A., Attwood, K. M., Davis, E. W., Mendicino, L. A., Hutson, A., Zirpoli, G. R., Tang, L., Nair, N. M., Barlow, W., Hershman, D. L., Unger, J. M., Moore, H. C. F., Isaacs, C., Hobday, T. J., Hortobagyi, G. N., Gralow, J. R., Albain, K. S., Budd, G. T., & Ambrosone, C. B. (2023). Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer. JAMA Network Open, 6(5), e2311673. https://doi.org/10.1001/jamanetworkopen.2023.11673

May, M. S., Jamison, J. K., Wong, W., Michel, A., Raufi, A. G., Neugut, A. I., & Manji, G. A. (2023). Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer. Cancer Investigation, 41(5), 487–490. https://doi.org/10.1080/07357907.2023.2203747

Suzuki, Y., Chen, L., Hou, J. Y., St. Clair, C. M., Khoury-Collado, F., de Meritens, A. B., Matsuo, K., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia. Obstetrics & Gynecology, 141(5), 979–987. https://doi.org/10.1097/aog.0000000000005124

Sahoo, S., Krings, G., Chen, Y.-Y., Carter, J. M., Chen, B., Guo, H., Hibshoosh, H., Reisenbichler, E., Fan, F., Wei, S., Khazai, L., Balassanian, R., Klein, M. E., Shad, S., Venters, S. J., Borowsky, A. D., Symmans, W. F., & Ocal, I. T. (2022). Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy. Archives of Pathology & Laboratory Medicine, 147(5), 591–603. https://doi.org/10.5858/arpa.2022-0021-ep

Graff, S. L., Bansal, R., Adeyelu, T., Elliott, A., Bustos, M., Rodriguez, E., Accordino, M., Meisel, J., Gatti-Mays, M., Hsu, E., Lathrop, K. I., Kaklamani, V., Oberley, M., Sledge, G., & Sammons, S. (2023). 215P Impact of HER2 low on survival in patients treated with standard therapies in advanced breast cancer. ESMO Open, 8(1), 101404. https://doi.org/10.1016/j.esmoop.2023.101404

Moore, C. E., Yalcindag, S. E., Czeladko, H., Ravindranathan, R., Wijesekara Hanthi, Y., Levy, J. C., Sannino, V., Schindler, D., Ciccia, A., Costanzo, V., & Elia, A. E. H. (2023). RFWD3 promotes ZRANB3 recruitment to regulate the remodeling of stalled replication forks. Journal of Cell Biology, 222(5). https://doi.org/10.1083/jcb.202106022

Labadie, B. W., & Fojo, A. T. (2023). Requirements for Meaningful Progress in the Therapy of Neuroendocrine Cancers. JAMA Oncology, 9(5), 606. https://doi.org/10.1001/jamaoncol.2022.7842

Goodstein, T., Yang, Y., Runcie, K., Srinivasan, R., & Singer, E. A. (2023). Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma. Current Opinion in Oncology, 35(3), 206–217. https://doi.org/10.1097/cco.0000000000000939

Lawrence, W. R., McDonald, J. A., Williams, F., Shiels, M. S., Freedman, N. D., Lin, Z., & Magnani, J. W. (2023). Stressful Life Events, Social Support, and Incident Breast Cancer by Estrogen Receptor Status. Cancer Prevention Research, 16(5), 259–267. https://doi.org/10.1158/1940-6207.capr-22-0472

Ravi, A., Hellmann, M. D., Arniella, M. B., Holton, M., Freeman, S. S., Naranbhai, V., Stewart, C., Leshchiner, I., Kim, J., Akiyama, Y., Griffin, A. T., Vokes, N. I., Sakhi, M., Kamesan, V., Rizvi, H., Ricciuti, B., Forde, P. M., Anagnostou, V., Riess, J. W., … Gainor, J. F. (2023). Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. Nature Genetics, 55(5), 807–819. https://doi.org/10.1038/s41588-023-01355-5

Dix-Peek, T., Phakathi, B. P., van den Berg, E. J., Dickens, C., Augustine, T. N., Cubasch, H., Neugut, A. I., Jacobson, J. S., Joffe, M., Ruff, P., & Duarte, R. A. B. (2023). Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Research and Treatment, 199(1), 1–12. https://doi.org/10.1007/s10549-023-06886-3

Carneiro, B. A., Papadopoulos, K. P., Strickler, J. H., Lassman, A. B., Waqar, S. N., Chae, Y. K., Patel, J. D., Shacham-Shmueli, E., Kelly, K., Khasraw, M., Bestvina, C. M., Merrell, R., Huang, K., Atluri, H., Ansell, P., Li, R., Jin, J., Anderson, M. G., Reilly, E. B., … Gan, H. K. (2022). Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Neuro-Oncology Advances, 5(1). https://doi.org/10.1093/noajnl/vdac183

Jim, H. S. L., Brady-Nicholls, R., & Hershman, D. L. (2023). The importance of patient-reported outcomes in pragmatic clinical trials. JNCI: Journal of the National Cancer Institute, 115(4), 352–354. https://doi.org/10.1093/jnci/djad037

Li, Z., & Zhang, Z. (2023). Histone chaperones: A multinodal highway network inside the cell. Molecular Cell, 83(7), 1024–1026. https://doi.org/10.1016/j.molcel.2023.03.004

Ambrosini, G., Natale, C. A., Musi, E., Garyantes, T., & Schwartz, G. K. (2023). The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells. Cancer Research Communications, 3(4), 540–547. https://doi.org/10.1158/2767-9764.crc-22-0399

Cosper, P. F., Hrycyniak, L. C. F., Paracha, M., Lee, D. L., Wan, J., Jones, K., Bice, S. A., Nickel, K., Mallick, S., Taylor, A. M., Kimple, R. J., Lambert, P. F., & Weaver, B. A. (2023). HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E. Proceedings of the National Academy of Sciences, 120(14). https://doi.org/10.1073/pnas.2216700120

LaRose, M., Connolly, R. M., O’Sullivan, C. C., Velcheti, V., Vilimas, R., Gano, K., Bates, S. E., Pommier, Y., & Thomas, A. (2023). A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors. The Oncologist, 28(5), 460-e298. https://doi.org/10.1093/oncolo/oyad023

Wu, Y.-C., Kissner, M., & Momen-Heravi, F. (2023). A comprehensive multiparameter flow cytometry panel for immune profiling and functional studies of frozen tissue, bone marrow, and spleen. Journal of Immunological Methods, 515, 113444. https://doi.org/10.1016/j.jim.2023.113444

Lemmetyinen, T. T., Viitala, E. W., Wartiovaara, L., Kaprio, T., Hagström, J., Haglund, C., Katajisto, P., Wang, T. C., Domènech-Moreno, E., & Ollila, S. (2023). Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth. Disease Models & Mechanisms, 16(4). https://doi.org/10.1242/dmm.049692

Chidebe, R. C. W., Leibel, L. L., Orjiakor, T. C., Shrestha, A., Agha, A. A., Altinok Dindar, D., Kisakol, B., Ipiankama, S. C., Okoye, I. J., Mason, M., Auguste, A., & Esiaka, D. K. (2023). Promoting cancer prevention through World Cancer Day in Nigeria. The Lancet Oncology, 24(4), 319–322. https://doi.org/10.1016/s1470-2045(22)00692-1

Kastrinos, F., Kupfer, S. S., & Gupta, S. (2023). Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology, 164(5), 812–827. https://doi.org/10.1053/j.gastro.2023.02.021

Boila, L. D., Ghosh, S., Bandyopadhyay, S. K., Jin, L., Murison, A., Zeng, A. G. X., Shaikh, W., Bhowmik, S., Muddineni, S. S. N. A., Biswas, M., Sinha, S., Chatterjee, S. S., Mbong, N., Gan, O. I., Bose, A., Chakraborty, S., Arruda, A., Kennedy, J. A., Mitchell, A., … Sengupta, A. (2023). KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition. Leukemia, 37(4), 751–764. https://doi.org/10.1038/s41375-023-01833-z

Lee, S. M., Fan, W., Wang, A., Vaidya, R., Redman, M. W., Gettinger, S. N., Bazhenova, L., Herbst, R. S., Hershman, D. L., & Unger, J. M. (2023). Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO Clinical Cancer Informatics, 7. https://doi.org/10.1200/cci.22.00165

Su, Z., Kon, N., Yi, J., Zhao, H., Zhang, W., Tang, Q., Li, H., Kobayashi, H., Li, Z., Duan, S., Liu, Y., Olive, K. P., Zhang, Z., Honig, B., Manfredi, J. J., Rustgi, A. K., & Gu, W. (2023). Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism. Nature Cancer, 4(4), 564–581. https://doi.org/10.1038/s43018-023-00532-z

Shin, A. E., Giancotti, F. G., & Rustgi, A. K. (2023). Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends in Pharmacological Sciences, 44(4), 222–236. https://doi.org/10.1016/j.tips.2023.01.003